A detailed history of Wallington Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wallington Asset Management, LLC holds 1,401 shares of ABBV stock, worth $247,906. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,401
Holding current value
$247,906
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$163.84 - $199.33 $229,539 - $279,261
1,401 New
1,401 $277,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wallington Asset Management, LLC Portfolio

Follow Wallington Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wallington Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wallington Asset Management, LLC with notifications on news.